Trial Search Results
Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance
The goal of this study is to develop a non-invasive imaging test for in vivo detection of kidney transplant rejection. The hypotheses are that 1) Ferumoxytol-MRI can generate accurate estimates of tissue iron concentrations and tissue macrophages. 2) The signal given by a renal allograft on Ferumoxytol-MRI demonstrates significant differences between rejected and non-rejected transplants.
Stanford is currently not accepting patients for this trial.
Collaborator: Lucile Packard Children's Hospital
- Drug: Feraheme
- Other: MRI-GE Healthcare 3 Tesla magnet
- Completed solid organ transplant with referral for transplant follow-up
- Exclusion criteria comprise MR-incompatible metal implants, need of sedation (since an
anesthesia is not supported by this), claustrophobia or hemosiderosis/hemochromatosis.
Ages Eligible for Study
8 Years - 40 Years
Genders Eligible for Study